Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Severe short stature, Lymphocytic interstitial pneumonia, Respiratory distress, and Failure to thrive and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 3 | Severe short stature, Failure to thrive, Decreased response to growth hormone stimulation test |
STAT5B function has not been fully characterized.
Growth hormone insensitivity with immune dysregulation 1, autosomal recessive is caused by mutations in the STAT5B gene on chromosome 17.
Genetic testing for STAT5B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for growth hormone insensitivity with immune dysregulation 1, autosomal recessive has been reported in the published literature.
Phenotype severity distribution: 8 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for growth hormone insensitivity with immune dysregulation 1, autosomal recessive.
104 publications have been identified in PubMed for growth hormone insensitivity with immune dysregulation 1, autosomal recessive. Research spans Review / Meta-Analysis (70%), Basic Science / Preclinical (17%), and Epidemiology / Natural History (5%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 60 | 70% |
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 5:40 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Lungs and breathing
2 |
Lymphocytic interstitial pneumonia, Respiratory distress |
Hormones | 1 | Decreased response to growth hormone stimulation test |
Age of onset: childhood, infancy.
Laboratory research |
15 |
17% |
Disease patterns and progression | 4 | 5% |
Testing and diagnosis research | 3 | 3% |
Patient case studies | 3 | 3% |
Clinical study results | 1 | 1% |
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Dotan A (2025). [PMID: 39931017](https://pubmed.ncbi.nlm.nih.gov/39931017/). *Harefuah*. [Review / Meta-Analysis]
Sahoo SS (2025). [PMID: 39475954](https://pubmed.ncbi.nlm.nih.gov/39475954/). *Blood*. [Review / Meta-Analysis]
Karuntu JS (2025). [PMID: 39733931](https://pubmed.ncbi.nlm.nih.gov/39733931/). *Prog Retin Eye Res*. [Review / Meta-Analysis]
Thakur V (2025). [PMID: 40666020](https://pubmed.ncbi.nlm.nih.gov/40666020/). *Front Allergy*. [Review / Meta-Analysis]
Chuleerarux N (2025). [PMID: 39859044](https://pubmed.ncbi.nlm.nih.gov/39859044/). *Medicina (Kaunas)*. [Review / Meta-Analysis]
Sakuma H (2025). [PMID: 39143740](https://pubmed.ncbi.nlm.nih.gov/39143740/). *Dev Med Child Neurol*. [Review / Meta-Analysis]
Yacoub MR (2025). [PMID: 40747632](https://pubmed.ncbi.nlm.nih.gov/40747632/). *Curr Opin Allergy Clin Immunol*. [Review / Meta-Analysis]